glp-1 bacteria and Gut Health: Addressing Metabolic Dysfunction for Physicians Microbiota modulates the antidepressant effects

According to the Centers for Disease Control and Prevention, a body mass index of 30 or higher indicates obesity and a body mass index of 25 to 29.9 is considered overweight

Patients with severe gastrointestinal disease may require careful consideration and monitoring

At the same time, there is growing recognition that GLP-1 therapy reduces hepatic steatosis, triglycerides, and systemic inflammation

These sensitive pharmaceuticals must be maintained within strict temperature ranges, requiring packaging that ensures efficiency and safety throughout the supply chain

Serious but less common: pancreatitis, gallbladder problems, and low blood sugar (especially with insulin or sulfonylureas)

Lo que no todo el mundo sabe es que este trmino (abreviatura de pptido similar al glucagn tipo 1 en ingls) no es un producto de laboratorio, sino que se trata de una hormona -perteneciente al grupo de las incretinas- que nuestro organismo (concretamente el intestino) produce de forma natural cuando comemos y que desempea una serie de funciones relacionadas con el apetito: ayuda a regular los niveles de insulina en sangre (avisando al pncreas de que est entrando comida), ralentiza el vaciado gstrico (aumentando el tiempo durante el que no tenemos hambre) y enva seales de saciedad al cerebro